Skip to content

Artificial intelligence-assisted three-dimensional reconstruction of pulmonary nodules

Artificial intelligence-assisted three-dimensional reconstruction of pulmonary nodules

Status
Recruiting
Phases
Early Phase 1
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2100050985
Enrollment
Unknown
Registered
2021-09-09
Start date
2021-10-01
Completion date
Unknown
Last updated
2022-05-16

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

pulmonary nodules

Interventions

Gold Standard:1. Mainly based on the anatomical structure seen during the operation. 2. The Mimics anatomy marked by the doctor shall prevail.
Index test:1.&#32
Calculate&#32
the&#32
correct&#32
rate&#32
of&#32
correctly&#32
marking&#32
blood&#32
and&#32
trachea
2.&#32
The&#32
evaluation&#32
above&#32

Sponsors

Peking University Cancer Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: 1. Patients over the age of 18 who agree to join this clinical trial; 2. Our hospital has completed at least one chest CT (including enhanced CT); 3. The patient's pulmonary nodules are peripheral nodules.

Exclusion criteria

Exclusion criteria: None

Design outcomes

Primary

MeasureTime frame
The accuracy of AI 3D reconstruction of blood vessels and bronchi;

Countries

China

Contacts

Public ContactWu Nan

Peking University Cancer Hospital

nanwu@bjmu.edu.cn+86 13910154426

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 12, 2026